𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

✍ Scribed by Sarantaus, Laura; Huusko, Pia; Eerola, Hannaleena; Launonen, Virpi; Vehmanen, Paula; Rapakko, Katrin; Gillanders, Elizabeth; Syrjäkoski, Kirsi; Kainu, Tommi; Vahteristo, Pia

Book ID
110025022
Publisher
Nature Publishing Group
Year
2000
Tongue
English
Weight
156 KB
Volume
8
Category
Article
ISSN
1018-4813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival of breast cancer patients in BR
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: A relative survival analysis from Finland
✍ Hannaleena Eerola; Pia Vahteristo; Laura Sarantaus; Pentti Kyyrönen; Seppo Pyrhö 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

Reports on the prognosis of familial breast cancer patients have been contradictory. True differences in survival, if they exist, would have important implications for genetic counselling and in treatment of hereditary breast cancer. We assessed the survival rates of 359 familial breast cancer patie

Recurrent BRCA1 and BRCA2 germline mutat
Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population
✍ Ui-Soon Khoo; Kelvin Y.K. Chan; Annie N.Y. Cheung; W.C. Xue; D.H. Shen; K.Y. Fun 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Previous mutational analysis for BRCA gene mutations in sporadic ovarian cancer occurring in Chinese patients in Hong Kong identified six germline BRCA1 mutations and one germline BRCA2 mutation, six of which were novel (Khoo et al., 2000). Knowledge of BRCA gene mutations in the Chinese population

Prevalence of founder BRCA1 and BRCA2 mu
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary
✍ Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation